Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiation Injuries 3 Pancreatic Neoplasms 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Vulvar Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Rare Diseases 1 Pancreatic Cancer Non-resectable 1 Ovarian Neoplasms 1 Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1

Interventions

Doxorubicin 15 pembrolizumab 12 Surgical Procedures, Operative 8 Cyclophosphamide 8 Blood Specimen Collection 8 Ifosfamide 7 Gemcitabine 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 atezolizumab 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 pazopanib 3 liposomal doxorubicin 3 fludarabine 3 cabozantinib 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2 selinexor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Heavy Ion Radiotherapy × Clear all

NCT04219202 2026-03-10

Retro-Ion

University Hospital Heidelberg

Phase NA Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡